Skip to Main Content
Bora Acquires Pyros Pharmaceuticals to Bolster Upsher-Smith Rare Disease Product Portfolio
Upsher-Smith Laboratories, LLC
Home
Capabilities
Products
Products A-Z
Our Brands
Product Patents
Corporate Development
Corporate Development
NASPA Innovation Map
About Us
About Upsher-Smith
History
Executive Team
Awards
Charitable Activity
Policies
News
Plant C
Careers
Careers at Upsher-Smith
Company Culture
Manufacturing
Military
Students & Interns
Contact Us
Contact Upsher-Smith
Locations
800-654-2299
Capabilities
Products
Products A-Z
Our Brands
Product Patents
Corporate Development
Corporate Development
NASPA Innovation Map
About Us
About Upsher-Smith
History
Executive Team
Awards
Charitable Activity
Policies
Careers
Careers at Upsher-Smith
Company Culture
Manufacturing
Military
Students & Interns
Contact Us
Contact Upsher-Smith
Locations
Plant C
News
800-654-2299
FY2020 Financial Results for fiscal year ended March 31, 2021
May 13, 2021
Company News
Share:
Share on Facebook
Share on Twitter
Share on LinkedIn
Share via Email
Press Release
Summary of Financial Results for Fiscal Year Ended March 31, 2021
Upsher-Smith and Rafarm Announce Launch of Moxifloxacin Ophthalmic Solution, USP 0.5%
Careers
Join Our Team!
We’re hiring
Search Our Jobs
Close
